Inflammation  >>  diclofenac sodium topical  >>  Phase 3
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
diclofenac sodium topical / Generic mfg.
2010-020521-40: Evaluation of therapeutic equivalence of diclofenac gel 1% formulation compared to Voltaren emulGel 1% gel in subjects with traumatic pathology: a double blind, randomized, phase III multicentre study.

Completed
3
220
Europe
diclofenac gel, VOLTAREN EMULGEL*GEL 60G 1%, VOLTAREN EMULGEL*GEL 60G 1%
EPIFARMA S.R.L.
Painful and traumatic inflammation of the joints, muscles, tendons and ligaments.
 
 
2015-001779-29: Multicenter clinical trial to evaluate efficacy and safety of diclofenac 1% gel produced by Epifarma s.r.l. compared to Voltaren® Emulgel® 1% gel

Completed
3
749
Europe
Diclofenac 1% gel, Gel, Voltaren Emulgel® 1% gel
Epifarma s.r.l., Epifarma s.r.l.
Patients with acute painful and flogistic (inflammatory) disease due to acute traumatic events (injury/contusion) of joints, muscles, tendons and ligaments, Patients with injury/contusion of joints, muscles, tendons and ligaments, Diseases [C] - Musculoskeletal Diseases [C05]
 
 

Download Options